Locally Advanced Non-Small Cell Lung Cancer (NSCLC) research hub

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

This study is testing new combinations of medicines for advanced lung cancer. It compares two new drugs with standard chemotherapy, or one new drug with standard chemotherapy, to see which works best and is safest for people with non-small cell lung cancer that has spread.